Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, July 08, 2026 (GLOBE NEWSWIRE) -- The "Single-Use Bioreactor Bags Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The single-use bioreactor bags market...
-
Teva-discovered TEV-’408 targets IL-15, a key driver of vitiligo biology TEV-’408 showed improvement in skin pigmentation and was well-tolerated with no safety signals observed to dateNearly 75% of...
-
Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease - Pipeline Insight, 2026" has been added to ResearchAndMarkets.com's offering. The "Minimal Residual Disease - Pipeline...
-
Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Rituximab Sales Forecast, and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. Key Factors Driving Rituximab...
-
Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Cancer Biologics Market: Industry Trends and Global Forecasts (Till 2035) - Distribution by Type of Biologic, Target Indication and Geography" has been...
-
Dublin, June 11, 2026 (GLOBE NEWSWIRE) -- The "Antibody Collaboration and Licensing Deals 2019-2026" report has been added to ResearchAndMarkets.com's offering. Antibody therapeutics carried...
-
Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Pemphigus Vulgaris Market - A Global and Regional Analysis: Focus on Treatment, Distribution Channel, Country, 2026-2036" report has been added to ...
-
Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Bioanalytical Testing Services Market by Type of Testing, Type of Modality, End-user, and Geographical Regions - Trends and Forecast, Till 2035" report...
-
Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Single Use Bioreactors Market (4th Edition): Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Bioreactor, Scale of Operation,...
-
Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Benlysta Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report offers insights into...